ArticleOPEN ACCESS

Correction: Klotho is a novel marker and cell survival factor in a subset of triple negative breast cancers (Oncotarget (2016) 7 (2611-2628) DOI: 10.18632/oncotarget.6006)

Oncotarget
ISSN: 19492553
1Citations
Citations of this article
6Readers
Mendeley users who have this article in their library.

Abstract

This article has been corrected: The correct Keywords are given below: Keywords: LCTL; gamma Klotho; FGF; breast cancer; cancer therapy; ROS; oxidative stress; oncogene.

Cite

CITATION STYLE

APA

Trošt, N., Peña-Llopis, S., Koirala, S., Stojan, J., Potts, P. R., Tacer, K. F., & Martinez, E. D. (2019, January 1). Correction: Klotho is a novel marker and cell survival factor in a subset of triple negative breast cancers (Oncotarget (2016) 7 (2611-2628) DOI: 10.18632/oncotarget.6006). Oncotarget. Impact Journals LLC.

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free